Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

Meme KanseriThe Serum HER-2/neu Test and Metastatic Breast Cancer

Serum HER-2

Serum HER-2/neu: Helping Women with Metastatic Breast Cancer

The Serum HER-2/neu test is a simple blood test for over 150,000 women living with metastatic breast cancer.1 For the thousands of women diagnosed with metastatic breast cancer each year, the Siemens Serum HER-2/neu test is the only Serum HER-2/neu test available for sale in the U.S. for monitoring their Serum HER-2/neu status during therapy. The Serum HER-2/neu test is indicated for monitoring patients with metastatic breast cancer and initial serum level >15 ng/ml.
 

Serum HER-2/neu Status: Providing Critical Information for Metastatic Disease Assessment

Decreasing levels of Serum HER-2/neu reflect treatment response or disease stability. Increasing levels of Serum HER-2/neu reflect disease progression.*

Monitoring Serum HER-2/neu levels yields important information about response to therapy and cancer progression, and may help physicians make more informed decisions when developing and modifying patient treatment regimen. 2-4  

1
2
3
4